Trial intelligence / Profile preview

Faropenem-based regimen versus standard regimen for newly diagnosed etiology-positive pulmonary tuberculosis

ChiCTR1800015959Phase 4Recruiting

Sponsor

Zhejiang University

Start

May 2018

Modality

Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1